Estimate Recalculated Sep 9, 2024 12:26AM EST
John P Brancaccio does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ALFACELL CORP, Synergy Pharmaceuticals, Inc., Accustem Sciences Inc., Hepion Pharmaceuticals, Inc., TrovaGene Inc., OKYO Pharma Ltd, and CALLISTO PHARMACEUTICALS INC.
John P Brancaccio's CIK is 0001276551
2014 was John P Brancaccio's most active year for acquiring shares with 11 total transactions. John P Brancaccio's most active month to acquire stocks was the month of May. 2013 was John P Brancaccio's most active year for disposing of shares, totalling 43 transactions. John P Brancaccio's most active month to dispose stocks was the month of December. 2018 saw John P Brancaccio paying a total of $1,794,011.50 for 307,490 shares, this is the most they've acquired in one year. In 2016 John P Brancaccio cashed out on 5,036 shares for a total of $14,503.68, their largest year based on trade value.
Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!